Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography
To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA). Cross-sectional study. Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT0155240...
Gespeichert in:
Veröffentlicht in: | American journal of ophthalmology 2020-01, Vol.209, p.99-106 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 106 |
---|---|
container_issue | |
container_start_page | 99 |
container_title | American journal of ophthalmology |
container_volume | 209 |
creator | Fan, Wenying Nittala, Muneeswar Gupta Fleming, Alan Robertson, Gavin Uji, Akihito Wykoff, Charles C. Brown, David M. van Hemert, Jano Ip, Michael Wang, Kang Falavarjani, Khalil Ghasemi Singer, Michael Sagong, Min Sadda, SriniVas R. |
description | To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA).
Cross-sectional study.
Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT01552408) and RECOVERY (NCT02863354) studies were stereographically projected at the Doheny Image Reading Center. The retinal vasculature was extracted from an early-phase FA frame by exploiting the elongated nature of the vessels and then skeletonized for calculation of FD using a box-counting method. The nonperfusion area was delineated by 2 independent, reading center–certified graders who were masked to the study groups and who were using a standardized protocol and then computed in millimeters squared.
While no difference in FD was observed for the entire retina in DR compared with normal control subjects, a significantly smaller FD was found in the far-periphery of the DR eyes (P < .001). FD for the entire retina was negatively associated with global nonperfusion area (R = −0.44; P < .001), and this relationship was also present within the 3 concentric retinal zones (posterior: R = −0.31, P = .016; midperiphery: R = −0.35, P = .007; and far periphery: R = −0.31, P = .015).
Peripheral FD on ultrawide-field FA is reduced in DR eyes compared with normal eyes and is correlated with severity of retinal nonperfusion. FD can be calculated automatically without the need for correction of peripheral distortion, and therefore it may prove to be a useful surrogate biomarker when precise quantification of nonperfusion is not feasible. |
doi_str_mv | 10.1016/j.ajo.2019.08.015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2283105472</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002939419304167</els_id><sourcerecordid>2323396901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-13f361db17180845b854b2e46f7e375ca6b3541309ab39afb76f57cc50a228e43</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EotvCD-CCInHhkuCJnTgRp7Z0AakCqaJny3EmXUdZO9gJ1V755UzZwoEDp5E933savcfYK-AFcKjfjYUZQ1FyaAveFByqJ2wDjWpzaFp4yjac8zJvRStP2GlKIz1rJdVzdiJAqhJqvmE_b3Ayiws-7dycXeByj-izG1ycN1O2jcYuND-4PfpEVGZ8n30JfsY4rL8_nKet6Uhgj7Iwm2V3yGh1Oy3R3Lse863Dqc-20xoiJoukOfd3LtxFM-8OL9izwUwJXz7OM3a7vfp2-Sm__vrx8-X5dW6lVEsOYhA19B0oaHgjq66pZFeirAeFQlXW1J2oJAjemk60ZuhUPVTK2oqbsmxQijP29ug7x_B9xbTovaNjpsl4DGvSRAngFSVD6Jt_0DGskRIhSpRCtHXLgSg4UjaGlCIOeo5ub-JBA9cPBelRU0H6oSDNG00Fkeb1o_Pa7bH_q_jTCAHvjwBSFD8cRp2sQ2-xdxHtovvg_mP_C8dfoZM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2323396901</pqid></control><display><type>article</type><title>Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Fan, Wenying ; Nittala, Muneeswar Gupta ; Fleming, Alan ; Robertson, Gavin ; Uji, Akihito ; Wykoff, Charles C. ; Brown, David M. ; van Hemert, Jano ; Ip, Michael ; Wang, Kang ; Falavarjani, Khalil Ghasemi ; Singer, Michael ; Sagong, Min ; Sadda, SriniVas R.</creator><creatorcontrib>Fan, Wenying ; Nittala, Muneeswar Gupta ; Fleming, Alan ; Robertson, Gavin ; Uji, Akihito ; Wykoff, Charles C. ; Brown, David M. ; van Hemert, Jano ; Ip, Michael ; Wang, Kang ; Falavarjani, Khalil Ghasemi ; Singer, Michael ; Sagong, Min ; Sadda, SriniVas R.</creatorcontrib><description>To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA).
Cross-sectional study.
Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT01552408) and RECOVERY (NCT02863354) studies were stereographically projected at the Doheny Image Reading Center. The retinal vasculature was extracted from an early-phase FA frame by exploiting the elongated nature of the vessels and then skeletonized for calculation of FD using a box-counting method. The nonperfusion area was delineated by 2 independent, reading center–certified graders who were masked to the study groups and who were using a standardized protocol and then computed in millimeters squared.
While no difference in FD was observed for the entire retina in DR compared with normal control subjects, a significantly smaller FD was found in the far-periphery of the DR eyes (P < .001). FD for the entire retina was negatively associated with global nonperfusion area (R = −0.44; P < .001), and this relationship was also present within the 3 concentric retinal zones (posterior: R = −0.31, P = .016; midperiphery: R = −0.35, P = .007; and far periphery: R = −0.31, P = .015).
Peripheral FD on ultrawide-field FA is reduced in DR eyes compared with normal eyes and is correlated with severity of retinal nonperfusion. FD can be calculated automatically without the need for correction of peripheral distortion, and therefore it may prove to be a useful surrogate biomarker when precise quantification of nonperfusion is not feasible.</description><identifier>ISSN: 0002-9394</identifier><identifier>EISSN: 1879-1891</identifier><identifier>DOI: 10.1016/j.ajo.2019.08.015</identifier><identifier>PMID: 31472160</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Angiogenesis Inhibitors - therapeutic use ; Combined Modality Therapy ; Cross-Sectional Studies ; Diabetic retinopathy ; Diabetic Retinopathy - diagnosis ; Diabetic Retinopathy - physiopathology ; Diabetic Retinopathy - therapy ; Female ; Fluorescein Angiography - methods ; Fractals ; Humans ; Intravitreal Injections ; Ischemia - diagnosis ; Ischemia - physiopathology ; Laser Coagulation ; Macular Edema - diagnosis ; Macular Edema - physiopathology ; Macular Edema - therapy ; Male ; Medical imaging ; Middle Aged ; Ophthalmology ; Prospective Studies ; Ranibizumab - therapeutic use ; Receptors, Vascular Endothelial Growth Factor - therapeutic use ; Recombinant Fusion Proteins - therapeutic use ; Retina ; Retinal Vessels - pathology ; Vascular Endothelial Growth Factor A - antagonists & inhibitors</subject><ispartof>American journal of ophthalmology, 2020-01, Vol.209, p.99-106</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Inc.</rights><rights>Copyright Elsevier Limited Jan 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-13f361db17180845b854b2e46f7e375ca6b3541309ab39afb76f57cc50a228e43</citedby><cites>FETCH-LOGICAL-c447t-13f361db17180845b854b2e46f7e375ca6b3541309ab39afb76f57cc50a228e43</cites><orcidid>0000-0003-1304-4101 ; 0000-0003-4140-5015</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajo.2019.08.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31472160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fan, Wenying</creatorcontrib><creatorcontrib>Nittala, Muneeswar Gupta</creatorcontrib><creatorcontrib>Fleming, Alan</creatorcontrib><creatorcontrib>Robertson, Gavin</creatorcontrib><creatorcontrib>Uji, Akihito</creatorcontrib><creatorcontrib>Wykoff, Charles C.</creatorcontrib><creatorcontrib>Brown, David M.</creatorcontrib><creatorcontrib>van Hemert, Jano</creatorcontrib><creatorcontrib>Ip, Michael</creatorcontrib><creatorcontrib>Wang, Kang</creatorcontrib><creatorcontrib>Falavarjani, Khalil Ghasemi</creatorcontrib><creatorcontrib>Singer, Michael</creatorcontrib><creatorcontrib>Sagong, Min</creatorcontrib><creatorcontrib>Sadda, SriniVas R.</creatorcontrib><title>Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography</title><title>American journal of ophthalmology</title><addtitle>Am J Ophthalmol</addtitle><description>To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA).
Cross-sectional study.
Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT01552408) and RECOVERY (NCT02863354) studies were stereographically projected at the Doheny Image Reading Center. The retinal vasculature was extracted from an early-phase FA frame by exploiting the elongated nature of the vessels and then skeletonized for calculation of FD using a box-counting method. The nonperfusion area was delineated by 2 independent, reading center–certified graders who were masked to the study groups and who were using a standardized protocol and then computed in millimeters squared.
While no difference in FD was observed for the entire retina in DR compared with normal control subjects, a significantly smaller FD was found in the far-periphery of the DR eyes (P < .001). FD for the entire retina was negatively associated with global nonperfusion area (R = −0.44; P < .001), and this relationship was also present within the 3 concentric retinal zones (posterior: R = −0.31, P = .016; midperiphery: R = −0.35, P = .007; and far periphery: R = −0.31, P = .015).
Peripheral FD on ultrawide-field FA is reduced in DR eyes compared with normal eyes and is correlated with severity of retinal nonperfusion. FD can be calculated automatically without the need for correction of peripheral distortion, and therefore it may prove to be a useful surrogate biomarker when precise quantification of nonperfusion is not feasible.</description><subject>Adult</subject><subject>Angiogenesis Inhibitors - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Cross-Sectional Studies</subject><subject>Diabetic retinopathy</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Diabetic Retinopathy - physiopathology</subject><subject>Diabetic Retinopathy - therapy</subject><subject>Female</subject><subject>Fluorescein Angiography - methods</subject><subject>Fractals</subject><subject>Humans</subject><subject>Intravitreal Injections</subject><subject>Ischemia - diagnosis</subject><subject>Ischemia - physiopathology</subject><subject>Laser Coagulation</subject><subject>Macular Edema - diagnosis</subject><subject>Macular Edema - physiopathology</subject><subject>Macular Edema - therapy</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Middle Aged</subject><subject>Ophthalmology</subject><subject>Prospective Studies</subject><subject>Ranibizumab - therapeutic use</subject><subject>Receptors, Vascular Endothelial Growth Factor - therapeutic use</subject><subject>Recombinant Fusion Proteins - therapeutic use</subject><subject>Retina</subject><subject>Retinal Vessels - pathology</subject><subject>Vascular Endothelial Growth Factor A - antagonists & inhibitors</subject><issn>0002-9394</issn><issn>1879-1891</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhS0EotvCD-CCInHhkuCJnTgRp7Z0AakCqaJny3EmXUdZO9gJ1V755UzZwoEDp5E933savcfYK-AFcKjfjYUZQ1FyaAveFByqJ2wDjWpzaFp4yjac8zJvRStP2GlKIz1rJdVzdiJAqhJqvmE_b3Ayiws-7dycXeByj-izG1ycN1O2jcYuND-4PfpEVGZ8n30JfsY4rL8_nKet6Uhgj7Iwm2V3yGh1Oy3R3Lse863Dqc-20xoiJoukOfd3LtxFM-8OL9izwUwJXz7OM3a7vfp2-Sm__vrx8-X5dW6lVEsOYhA19B0oaHgjq66pZFeirAeFQlXW1J2oJAjemk60ZuhUPVTK2oqbsmxQijP29ug7x_B9xbTovaNjpsl4DGvSRAngFSVD6Jt_0DGskRIhSpRCtHXLgSg4UjaGlCIOeo5ub-JBA9cPBelRU0H6oSDNG00Fkeb1o_Pa7bH_q_jTCAHvjwBSFD8cRp2sQ2-xdxHtovvg_mP_C8dfoZM</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Fan, Wenying</creator><creator>Nittala, Muneeswar Gupta</creator><creator>Fleming, Alan</creator><creator>Robertson, Gavin</creator><creator>Uji, Akihito</creator><creator>Wykoff, Charles C.</creator><creator>Brown, David M.</creator><creator>van Hemert, Jano</creator><creator>Ip, Michael</creator><creator>Wang, Kang</creator><creator>Falavarjani, Khalil Ghasemi</creator><creator>Singer, Michael</creator><creator>Sagong, Min</creator><creator>Sadda, SriniVas R.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1304-4101</orcidid><orcidid>https://orcid.org/0000-0003-4140-5015</orcidid></search><sort><creationdate>202001</creationdate><title>Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography</title><author>Fan, Wenying ; Nittala, Muneeswar Gupta ; Fleming, Alan ; Robertson, Gavin ; Uji, Akihito ; Wykoff, Charles C. ; Brown, David M. ; van Hemert, Jano ; Ip, Michael ; Wang, Kang ; Falavarjani, Khalil Ghasemi ; Singer, Michael ; Sagong, Min ; Sadda, SriniVas R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-13f361db17180845b854b2e46f7e375ca6b3541309ab39afb76f57cc50a228e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Angiogenesis Inhibitors - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Cross-Sectional Studies</topic><topic>Diabetic retinopathy</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Diabetic Retinopathy - physiopathology</topic><topic>Diabetic Retinopathy - therapy</topic><topic>Female</topic><topic>Fluorescein Angiography - methods</topic><topic>Fractals</topic><topic>Humans</topic><topic>Intravitreal Injections</topic><topic>Ischemia - diagnosis</topic><topic>Ischemia - physiopathology</topic><topic>Laser Coagulation</topic><topic>Macular Edema - diagnosis</topic><topic>Macular Edema - physiopathology</topic><topic>Macular Edema - therapy</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Middle Aged</topic><topic>Ophthalmology</topic><topic>Prospective Studies</topic><topic>Ranibizumab - therapeutic use</topic><topic>Receptors, Vascular Endothelial Growth Factor - therapeutic use</topic><topic>Recombinant Fusion Proteins - therapeutic use</topic><topic>Retina</topic><topic>Retinal Vessels - pathology</topic><topic>Vascular Endothelial Growth Factor A - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fan, Wenying</creatorcontrib><creatorcontrib>Nittala, Muneeswar Gupta</creatorcontrib><creatorcontrib>Fleming, Alan</creatorcontrib><creatorcontrib>Robertson, Gavin</creatorcontrib><creatorcontrib>Uji, Akihito</creatorcontrib><creatorcontrib>Wykoff, Charles C.</creatorcontrib><creatorcontrib>Brown, David M.</creatorcontrib><creatorcontrib>van Hemert, Jano</creatorcontrib><creatorcontrib>Ip, Michael</creatorcontrib><creatorcontrib>Wang, Kang</creatorcontrib><creatorcontrib>Falavarjani, Khalil Ghasemi</creatorcontrib><creatorcontrib>Singer, Michael</creatorcontrib><creatorcontrib>Sagong, Min</creatorcontrib><creatorcontrib>Sadda, SriniVas R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fan, Wenying</au><au>Nittala, Muneeswar Gupta</au><au>Fleming, Alan</au><au>Robertson, Gavin</au><au>Uji, Akihito</au><au>Wykoff, Charles C.</au><au>Brown, David M.</au><au>van Hemert, Jano</au><au>Ip, Michael</au><au>Wang, Kang</au><au>Falavarjani, Khalil Ghasemi</au><au>Singer, Michael</au><au>Sagong, Min</au><au>Sadda, SriniVas R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography</atitle><jtitle>American journal of ophthalmology</jtitle><addtitle>Am J Ophthalmol</addtitle><date>2020-01</date><risdate>2020</risdate><volume>209</volume><spage>99</spage><epage>106</epage><pages>99-106</pages><issn>0002-9394</issn><eissn>1879-1891</eissn><abstract>To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA).
Cross-sectional study.
Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT01552408) and RECOVERY (NCT02863354) studies were stereographically projected at the Doheny Image Reading Center. The retinal vasculature was extracted from an early-phase FA frame by exploiting the elongated nature of the vessels and then skeletonized for calculation of FD using a box-counting method. The nonperfusion area was delineated by 2 independent, reading center–certified graders who were masked to the study groups and who were using a standardized protocol and then computed in millimeters squared.
While no difference in FD was observed for the entire retina in DR compared with normal control subjects, a significantly smaller FD was found in the far-periphery of the DR eyes (P < .001). FD for the entire retina was negatively associated with global nonperfusion area (R = −0.44; P < .001), and this relationship was also present within the 3 concentric retinal zones (posterior: R = −0.31, P = .016; midperiphery: R = −0.35, P = .007; and far periphery: R = −0.31, P = .015).
Peripheral FD on ultrawide-field FA is reduced in DR eyes compared with normal eyes and is correlated with severity of retinal nonperfusion. FD can be calculated automatically without the need for correction of peripheral distortion, and therefore it may prove to be a useful surrogate biomarker when precise quantification of nonperfusion is not feasible.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31472160</pmid><doi>10.1016/j.ajo.2019.08.015</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1304-4101</orcidid><orcidid>https://orcid.org/0000-0003-4140-5015</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9394 |
ispartof | American journal of ophthalmology, 2020-01, Vol.209, p.99-106 |
issn | 0002-9394 1879-1891 |
language | eng |
recordid | cdi_proquest_miscellaneous_2283105472 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adult Angiogenesis Inhibitors - therapeutic use Combined Modality Therapy Cross-Sectional Studies Diabetic retinopathy Diabetic Retinopathy - diagnosis Diabetic Retinopathy - physiopathology Diabetic Retinopathy - therapy Female Fluorescein Angiography - methods Fractals Humans Intravitreal Injections Ischemia - diagnosis Ischemia - physiopathology Laser Coagulation Macular Edema - diagnosis Macular Edema - physiopathology Macular Edema - therapy Male Medical imaging Middle Aged Ophthalmology Prospective Studies Ranibizumab - therapeutic use Receptors, Vascular Endothelial Growth Factor - therapeutic use Recombinant Fusion Proteins - therapeutic use Retina Retinal Vessels - pathology Vascular Endothelial Growth Factor A - antagonists & inhibitors |
title | Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A25%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20Between%20Retinal%20Fractal%20Dimension%20and%20Nonperfusion%20in%20Diabetic%20Retinopathy%20on%20Ultrawide-Field%20Fluorescein%20Angiography&rft.jtitle=American%20journal%20of%20ophthalmology&rft.au=Fan,%20Wenying&rft.date=2020-01&rft.volume=209&rft.spage=99&rft.epage=106&rft.pages=99-106&rft.issn=0002-9394&rft.eissn=1879-1891&rft_id=info:doi/10.1016/j.ajo.2019.08.015&rft_dat=%3Cproquest_cross%3E2323396901%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2323396901&rft_id=info:pmid/31472160&rft_els_id=S0002939419304167&rfr_iscdi=true |